Literature DB >> 7938014

Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity.

S Rabizadeh1, C M Bitler, L L Butcher, D E Bredesen.   

Abstract

The low-affinity nerve growth factor receptor (NGFR) p75NGFR induces apoptosis in the absence of nerve growth factor (NGF) binding but enhances neural survival when bound by NGF. Basal forebrain cholinergic neurons express the highest levels of p75NGFR in the adult human brain and are preferentially involved in Alzheimer disease, raising the question of whether there may be a functional relationship between the expression of p75NGFR and basal forebrain cholinergic neuronal degeneration in Alzheimer disease. The expression of p75NGFR by wild-type and mutant PC12 cells potentiated cell death induced by beta-amyloid peptide. NGF binding to p75NGFR inhibited the toxicity of beta-amyloid peptide, whereas NGF binding to TrkA, the high-affinity NGFR, enhanced it. These results suggest a possible link between beta-amyloid peptide toxicity and preferential degeneration of cells expressing p75NGFR.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7938014      PMCID: PMC45090          DOI: 10.1073/pnas.91.22.10703

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Cholinergic and non-cholinergic projections from the rat basal forebrain revealed by combined choline acetyltransferase and Phaseolus vulgaris leucoagglutinin immunohistochemistry.

Authors:  N J Woolf; M C Hernit; L L Butcher
Journal:  Neurosci Lett       Date:  1986-05-23       Impact factor: 3.046

2.  Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment.

Authors:  P T Francis; A M Palmer; N R Sims; D M Bowen; A N Davison; M M Esiri; D Neary; J S Snowden; G K Wilcock
Journal:  N Engl J Med       Date:  1985-07-04       Impact factor: 91.245

Review 3.  The role of the nucleus basalis of Meynert in dementia: review and reconsideration.

Authors:  J L Cummings; D F Benson
Journal:  Alzheimer Dis Assoc Disord       Date:  1987       Impact factor: 2.703

4.  The pontomesencephalotegmental cholinergic system does not degenerate in Alzheimer's disease.

Authors:  N J Woolf; R W Jacobs; L L Butcher
Journal:  Neurosci Lett       Date:  1989-01-30       Impact factor: 3.046

Review 5.  Biochemical studies of nerve cells and energy metabolism in Alzheimer's disease.

Authors:  D M Bowen; A N Davison
Journal:  Br Med Bull       Date:  1986-01       Impact factor: 4.291

6.  Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's disease.

Authors:  T Arendt; G Taubert; V Bigl; A Arendt
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

7.  Induction of apoptosis by the low-affinity NGF receptor.

Authors:  S Rabizadeh; J Oh; L T Zhong; J Yang; C M Bitler; L L Butcher; D E Bredesen
Journal:  Science       Date:  1993-07-16       Impact factor: 47.728

8.  Selective loss of central cholinergic neurons in Alzheimer's disease.

Authors:  P Davies; A J Maloney
Journal:  Lancet       Date:  1976-12-25       Impact factor: 79.321

9.  Lesions of the nucleus ansae peduncularis in neuropsychiatric disease.

Authors:  P Averback
Journal:  Arch Neurol       Date:  1981-04

10.  Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis.

Authors:  V Bigl; N J Woolf; L L Butcher
Journal:  Brain Res Bull       Date:  1982-06       Impact factor: 4.077

View more
  35 in total

1.  Elimination of the class A scavenger receptor does not affect amyloid plaque formation or neurodegeneration in transgenic mice expressing human amyloid protein precursors.

Authors:  F Huang; M Buttini; T Wyss-Coray; L McConlogue; T Kodama; R E Pitas; L Mucke
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

2.  Absence of p75NTR causes increased basal forebrain cholinergic neuron size, choline acetyltransferase activity, and target innervation.

Authors:  T T Yeo; J Chua-Couzens; L L Butcher; D E Bredesen; J D Cooper; J S Valletta; W C Mobley; F M Longo
Journal:  J Neurosci       Date:  1997-10-15       Impact factor: 6.167

3.  A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging.

Authors:  Claudio Costantini; Richard Weindruch; Giuliano Della Valle; Luigi Puglielli
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

Review 4.  The role of apoptosis in neurodegenerative diseases.

Authors:  P Desjardins; S Ledoux
Journal:  Metab Brain Dis       Date:  1998-06       Impact factor: 3.584

5.  Amyloid beta peptide of Alzheimer's disease downregulates Bcl-2 and upregulates bax expression in human neurons.

Authors:  E Paradis; H Douillard; M Koutroumanis; C Goodyer; A LeBlanc
Journal:  J Neurosci       Date:  1996-12-01       Impact factor: 6.167

Review 6.  Basal forebrain cholinergic dysfunction in Alzheimer's disease--interrelationship with beta-amyloid, inflammation and neurotrophin signaling.

Authors:  Reinhard Schliebs
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

7.  Low concentrations of aggregated beta-amyloid induce neurite formation via the neurotrophin receptor p75.

Authors:  K Susen; A Blöchl
Journal:  J Mol Med (Berl)       Date:  2005-07-07       Impact factor: 4.599

Review 8.  New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.

Authors:  Salvatore Salomone; Filippo Caraci; Gian Marco Leggio; Julia Fedotova; Filippo Drago
Journal:  Br J Clin Pharmacol       Date:  2012-04       Impact factor: 4.335

Review 9.  Binding Sites for Amyloid-β Oligomers and Synaptic Toxicity.

Authors:  Levi M Smith; Stephen M Strittmatter
Journal:  Cold Spring Harb Perspect Med       Date:  2017-05-01       Impact factor: 6.915

10.  The p75 neurotrophin receptor promotes amyloid-beta(1-42)-induced neuritic dystrophy in vitro and in vivo.

Authors:  Juliet K Knowles; Jayakumar Rajadas; Thuy-Vi V Nguyen; Tao Yang; Melburne C LeMieux; Lilith Vander Griend; Chihiro Ishikawa; Stephen M Massa; Tony Wyss-Coray; Frank M Longo
Journal:  J Neurosci       Date:  2009-08-26       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.